Benjamin F. Cravatt's most recent trade in FibroGen Inc was a trade of 70,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroGen Inc | Benjamin F. Cravatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) |